AU Stock MarketDetailed Quotes
PARO Paradigm Biopharmaceuticals Ltd
- 0.005
- 0.0000.00%
20min DelayMarket Closed Jun 27 13:55 AET
1.75MMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.005Pre Close0.00Turnover0.10052wk High0.00%Turnover Ratio350.36MShares0.00552wk Low--EPS TTM1.56MFloat Cap0.100Historical High0.00P/E (Static)312.80MShs Float0.005Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Paradigm Biopharmaceuticals Ltd Company
Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).
Company Profile
SymbolPARO
Company NameParadigm Biopharmaceuticals Ltd
Founded2014
MarketASX
Employees50
Fiscal Year Ends06-30
Address500 Collins Street Level 15
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 396295566
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Dr. Donna Skerrett
- Director and Chief Medical Officer
- --
- Paul Rennie
- Executive Chairman of the Board and Managing Director
- --
- Amos Meltzer
- Director
- --
- Helen Fisher, B.Sc. ,L.L.B.,L.L.M.
- Director
- --
- John Gaffney
- Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg